Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials.
Eron, Joseph J
Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials. [electronic resource] - The Lancet. Infectious diseases Jul 2013 - 587-96 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1474-4457
10.1016/S1473-3099(13)70093-8 doi
Adult
Anti-HIV Agents--administration & dosage
CD4 Lymphocyte Count
Double-Blind Method
Drug-Related Side Effects and Adverse Reactions--epidemiology
Female
HIV Infections--drug therapy
HIV-1--isolation & purification
Humans
Male
Middle Aged
Placebos--administration & dosage
Pyrrolidinones--administration & dosage
Raltegravir Potassium
Salvage Therapy--adverse effects
Treatment Outcome
Viral Load
Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials. [electronic resource] - The Lancet. Infectious diseases Jul 2013 - 587-96 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1474-4457
10.1016/S1473-3099(13)70093-8 doi
Adult
Anti-HIV Agents--administration & dosage
CD4 Lymphocyte Count
Double-Blind Method
Drug-Related Side Effects and Adverse Reactions--epidemiology
Female
HIV Infections--drug therapy
HIV-1--isolation & purification
Humans
Male
Middle Aged
Placebos--administration & dosage
Pyrrolidinones--administration & dosage
Raltegravir Potassium
Salvage Therapy--adverse effects
Treatment Outcome
Viral Load